Cheng P Y, Svingos A L, Wang H, Clarke C L, Jenab S, Beczkowska I W, Inturrisi C E, Pickel V M
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
J Neurosci. 1995 Sep;15(9):5976-88. doi: 10.1523/JNEUROSCI.15-09-05976.1995.
Opioid peptides, Met5- and Leu5-enkephalin, are known endogenous ligands for the delta-opioid receptor (DOR) associated with opioid analgesia at the spinal level. To determine the cellular sites for DOR-mediated actions, we examined the ultrastructural localization of DOR and Met5-enkephalin (ME) in the spinal cord by combining immunoperoxidase and immunogold-silver labeling for antibodies against DOR and ME, respectively. Antibodies for DOR localization were raised in guinea pig against peptide 34-47 (p34), an amino acid sequence within the extracellular N-terminus of the DOR recently cloned from mouse neuroblastoma glioma (NG-108) cells. Selective immunoperoxidase labeling for DOR was detected by light microscopy in NG-108 cells and in the lamina I and II of the dorsal horn of the spinal cord (C2-C4). Electron microscopy of these spinal laminae revealed that the majority of the punctate varicosities seen by light microscopy were axon terminals. delta-opioid receptor-like immunoreactivity (DOR-LI) in axon terminals was most prominently associated with large dense core vesicles, and sometimes seen along the membranes of small clear vesicles and segments of the plasmalemma. A semiquantitative analysis of dually labeled sections revealed that of the terminals showing DOR-LI, 23/102 (23%) also contained Met5-enkephalin-like immunoreactivity (ME-LI). Conversely, 23/35 (66%) of the terminals showing ME-LI also showed DOR-LI. In addition to the presynaptic localization, selective postsynaptic densities within dendrites were also occasionally (9%) immunolabeled for the opioid receptor. These results provide the first ultrastructural evidence that DOR may serve autoreceptor functions on ME terminals as well as presynaptic modulation of other transmitters in the dorsal horn of the rat spinal cord. Additionally, the vesicular localization of DOR-LI in axon terminals suggests the involvement of these organelles in the transport of the receptors to the plasma membrane.
阿片肽、甲硫氨酸脑啡肽和亮氨酸脑啡肽是已知的与脊髓水平阿片类镇痛相关的δ阿片受体(DOR)的内源性配体。为了确定DOR介导作用的细胞位点,我们通过分别针对DOR和甲硫氨酸脑啡肽(ME)的抗体进行免疫过氧化物酶和免疫金银标记,研究了脊髓中DOR和甲硫氨酸脑啡肽(ME)的超微结构定位。针对DOR定位的抗体是在豚鼠体内针对肽34-47(p34)产生的,该肽是最近从小鼠神经母细胞瘤胶质瘤(NG-108)细胞克隆的DOR细胞外N端的氨基酸序列。通过光学显微镜在NG-108细胞以及脊髓背角(C2-C4)的I层和II层中检测到DOR的选择性免疫过氧化物酶标记。对这些脊髓层的电子显微镜检查显示,光学显微镜下看到的大多数点状膨体是轴突终末。轴突终末中的δ阿片受体样免疫反应性(DOR-LI)最显著地与大的致密核心囊泡相关,有时也见于小的清亮囊泡膜和质膜片段。对双重标记切片的半定量分析显示,在显示DOR-LI的终末中,23/102(23%)也含有甲硫氨酸脑啡肽样免疫反应性(ME-LI)。相反,在显示ME-LI的终末中,23/35(66%)也显示DOR-LI。除了突触前定位外,树突内的选择性突触后致密物偶尔(9%)也被免疫标记为阿片受体。这些结果提供了首个超微结构证据,表明DOR可能在ME终末发挥自身受体功能,并对大鼠脊髓背角中的其他递质进行突触前调节。此外,轴突终末中DOR-LI的囊泡定位表明这些细胞器参与了受体向质膜的转运。